OurPharma recalls

OurPharma has 4 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 16 Sep 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is packaging defects.

Total recalls4since 2022

Last 12 months1reported

Class I00% of total

Ongoing1latest 16 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 1 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 1 0

Severity split

Class I 0 0%Class II 2 50%Class III 2 50%

Why ourpharma is recalled

Product types

Pain Medication4100%

By year

2026125%
2025125%
2023125%
2022125%

Ongoing ourpharma recalls

1 active

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS II	fentaNYL Citrate, 1,000 mcg recalled by OurPharma	OurPharma	Other	Nationwide

All ourpharma recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS II	fentaNYL Citrate, 1,000 mcg recalled by OurPharma	OurPharma	Other	Nationwide
30 Apr 2025Drug	CLASS III	HYDROmorphone Hydrochloride 50mg/ (1mg/mL) recalled by OurPharma	OurPharma	Potency & Assay	Nationwide
1 Feb 2023Drug	CLASS III	FentaNYL Citrate 2.5mg/ (50mcg/mL) Injection Solution recalled	OurPharma	Packaging Defects	IL, MO
21 Dec 2022Drug	CLASS II	FentaNYL Citrate 2.5 mg/ (50mcg/ml) Injection Solution recalled	OurPharma	Packaging Defects	MO

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.